BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28643766)

  • 1. Complexity of chromosomal rearrangements in Down syndrome leukemia.
    Ganguly BB; Kadam NN; Mandal PK
    J Cancer Res Ther; 2017; 13(2):381-383. PubMed ID: 28643766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrandom chromosomal aberrations and clonal chromosomal evolution in acute leukemia associated with Down's syndrome.
    Wang N; Leung J; Warrier RP; Schorin M; Kirkpatrick D; Nowak MJ; Strand R
    Cancer Genet Cytogenet; 1987 Sep; 28(1):155-62. PubMed ID: 2955885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
    Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
    J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique clinical and biological features of leukemia in Down syndrome children.
    Xavier AC; Ge Y; Taub J
    Expert Rev Hematol; 2010 Apr; 3(2):175-86. PubMed ID: 21083461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic studies in children with Down syndrome and acute leukemia.
    Valladares A; Palma-Padilla V; Mejía-Aranguré JM; Guevara-Yánez R; Lerma-Reyes A; Salamanca-Gómez F
    Leuk Res; 2005 Nov; 29(11):1241-6. PubMed ID: 16164980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down syndrome, drug metabolism and chromosome 21.
    Taub JW; Ge Y
    Pediatr Blood Cancer; 2005 Jan; 44(1):33-9. PubMed ID: 15390307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment results in children with myeloid leukemia of Down syndrome in Saudi Arabia: A multicenter SAPHOS leukemia group study.
    Jastaniah W; Alsultan A; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Abrar MB; Al Sudairy R; Al Ghemlas I
    Leuk Res; 2017 Jul; 58():48-54. PubMed ID: 28445808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
    Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
    Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down syndrome and leukemia, an update.
    Drabkin HA; Erickson P
    Prog Clin Biol Res; 1995; 393():169-76. PubMed ID: 8545449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome: a report from the Children's Oncology Group.
    Puumala SE; Ross JA; Olshan AF; Robison LL; Smith FO; Spector LG
    Cancer; 2007 Nov; 110(9):2067-74. PubMed ID: 17849462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletions of chromosome 21 restricted to the leukemic cells of children with Down syndrome and leukemia.
    Kempski HM; Chessells JM; Reeves BR
    Leukemia; 1997 Nov; 11(11):1973-7. PubMed ID: 9369434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down syndrome preleukemia and leukemia.
    Maloney KW; Taub JW; Ravindranath Y; Roberts I; Vyas P
    Pediatr Clin North Am; 2015 Feb; 62(1):121-37. PubMed ID: 25435116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome for Down syndrome patients with hematopoietic disorders.
    Li MJ; Lee NC; Yang YL; Yen HJ; Chang HH; Chien YH; Lu MY; Jou ST; Lin KH; Hwu WL; Lin DT
    J Formos Med Assoc; 2016 Feb; 115(2):94-9. PubMed ID: 26234152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.
    Gamis AS
    Pediatr Blood Cancer; 2005 Jan; 44(1):13-20. PubMed ID: 15534881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
    Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
    Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
    Creutzig U; Reinhardt D; Diekamp S; Dworzak M; Stary J; Zimmermann M
    Leukemia; 2005 Aug; 19(8):1355-60. PubMed ID: 15920490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
    Tigay JH
    J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
    D'Angelo G; Merlo P
    Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic and molecular studies of Down syndrome individuals with leukemia.
    Shen JJ; Williams BJ; Zipursky A; Doyle J; Sherman SL; Jacobs PA; Shugar AL; Soukup SW; Hassold TJ
    Am J Hum Genet; 1995 Apr; 56(4):915-25. PubMed ID: 7717402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.